|
US4733665C2
(en)
|
1985-11-07 |
2002-01-29 |
Expandable Grafts Partnership |
Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
|
|
US5135919A
(en)
|
1988-01-19 |
1992-08-04 |
Children's Medical Center Corporation |
Method and a pharmaceutical composition for the inhibition of angiogenesis
|
|
DE3827340A1
(de)
*
|
1988-08-12 |
1990-02-15 |
Hoechst Ag |
Verwendung von (alpha)-aminoboronsaeure-derivaten zur prophylaxe und behandlung von viruserkrankungen
|
|
JPH0291023U
(OSRAM)
|
1989-01-05 |
1990-07-19 |
|
|
|
US5441944A
(en)
|
1989-04-23 |
1995-08-15 |
The Trustees Of The University Of Pennsylvania |
Substituted cyclodextrin sulfates and their uses as growth modulating agents
|
|
US5071957A
(en)
|
1989-08-04 |
1991-12-10 |
Bristol-Myers Company |
Antibiotic BU-4061T
|
|
US4990448A
(en)
|
1989-08-04 |
1991-02-05 |
Bristol-Myers Company |
Bu-4061T
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
HUT62312A
(en)
|
1990-03-05 |
1993-04-28 |
Cephalon Inc |
Process for producing chymotrypsin-like proteases and their inhibitors
|
|
US5340736A
(en)
|
1991-05-13 |
1994-08-23 |
The President & Fellows Of Harvard College |
ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting
|
|
GB9300048D0
(en)
|
1993-01-04 |
1993-03-03 |
Wellcome Found |
Endothelin converting enzyme inhibitors
|
|
TW380137B
(en)
|
1994-03-04 |
2000-01-21 |
Merck & Co Inc |
Process for making an epoxide
|
|
US5693617A
(en)
|
1994-03-15 |
1997-12-02 |
Proscript, Inc. |
Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
|
|
US6660268B1
(en)
|
1994-03-18 |
2003-12-09 |
The President And Fellows Of Harvard College |
Proteasome regulation of NF-KB activity
|
|
US6506876B1
(en)
|
1994-10-11 |
2003-01-14 |
G.D. Searle & Co. |
LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
|
|
US6083903A
(en)
|
1994-10-28 |
2000-07-04 |
Leukosite, Inc. |
Boronic ester and acid compounds, synthesis and uses
|
|
DE19505263A1
(de)
|
1995-02-16 |
1996-08-22 |
Consortium Elektrochem Ind |
Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten
|
|
US6335358B1
(en)
|
1995-04-12 |
2002-01-01 |
President And Fellows Of Harvard College |
Lactacystin analogs
|
|
US6150415A
(en)
|
1996-08-13 |
2000-11-21 |
The Regents Of The University Of California |
Epoxide hydrolase complexes and methods therewith
|
|
WO1998010779A1
(en)
|
1996-09-13 |
1998-03-19 |
New York University |
Method for treating parasitic diseases with proteasome inhibitors
|
|
SI0932617T1
(en)
|
1996-10-18 |
2002-06-30 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
|
HU227742B1
(en)
|
1996-10-18 |
2012-02-28 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
|
US6046177A
(en)
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
|
US5874418A
(en)
|
1997-05-05 |
1999-02-23 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
|
DE69819721T2
(de)
|
1997-06-13 |
2004-09-23 |
Cydex Inc., Overland Park |
Zusammensetzung mit erhöhter lagerstabilität enthaltend cyclodextrin und wirkstoffe oder wirkstoff-vorstufen, die in wasserunlösliche komponenten zersetzt werden
|
|
US6133308A
(en)
|
1997-08-15 |
2000-10-17 |
Millennium Pharmaceuticals, Inc. |
Synthesis of clasto-lactacystin beta-lactone and analogs thereof
|
|
US6075150A
(en)
|
1998-01-26 |
2000-06-13 |
Cv Therapeutics, Inc. |
α-ketoamide inhibitors of 20S proteasome
|
|
US6099851A
(en)
|
1998-06-02 |
2000-08-08 |
Weisman; Kenneth M. |
Therapeutic uses of leuprolide acetate
|
|
US6462019B1
(en)
|
1998-07-10 |
2002-10-08 |
Osteoscreen, Inc. |
Inhibitors of proteasomal activity and production for stimulating bone growth
|
|
US6902721B1
(en)
|
1998-07-10 |
2005-06-07 |
Osteoscreen, Inc. |
Inhibitors of proteasomal activity for stimulating bone growth
|
|
US6838436B1
(en)
|
1998-07-10 |
2005-01-04 |
Osteoscreen Inc. |
Inhibitors of proteasomal activity for stimulating bone growth
|
|
US6204257B1
(en)
|
1998-08-07 |
2001-03-20 |
Universtiy Of Kansas |
Water soluble prodrugs of hindered alcohols
|
|
KR20010080267A
(ko)
|
1998-10-20 |
2001-08-22 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
프로테아솜 억제제 약물 작용을 모니터링하는 방법
|
|
US6492333B1
(en)
|
1999-04-09 |
2002-12-10 |
Osteoscreen, Inc. |
Treatment of myeloma bone disease with proteasomal and NF-κB activity inhibitors
|
|
US6831099B1
(en)
|
1999-05-12 |
2004-12-14 |
Yale University |
Enzyme inhibition
|
|
CA2385958A1
(en)
|
1999-10-20 |
2001-04-26 |
Osteoscreen, Inc. |
Inhibitors of proteasomal activity for stimulating bone and hair growth
|
|
EP2305291A1
(de)
|
2000-10-12 |
2011-04-06 |
ViroLogik GmbH |
Verwendung von Proteasome Hemmern zur Behandlung von HIV Infektionen
|
|
US6699835B2
(en)
|
2001-01-25 |
2004-03-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Formulation of boronic acid compounds
|
|
US6740674B2
(en)
|
2001-05-21 |
2004-05-25 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
|
ATE317850T1
(de)
*
|
2001-05-30 |
2006-03-15 |
Novartis Pharma Gmbh |
2-((n-(2-amino-3-(heteroaryl- oder - aryl)propionyl)aminoacyl)amino)- alkylboronsäurederivate
|
|
JP4412586B2
(ja)
|
2002-01-08 |
2010-02-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
エポネマイシンおよびエポキソマイシン類似物およびそれらの用途
|
|
US20040116329A1
(en)
|
2002-01-29 |
2004-06-17 |
Epstein Stephen E. |
Inhibition of proteasomes to prevent restenosis
|
|
WO2003086283A2
(en)
|
2002-04-09 |
2003-10-23 |
Greenville Hospital System |
Metastasis modulating activity of highly sulfated oligosaccharides
|
|
US7968569B2
(en)
|
2002-05-17 |
2011-06-28 |
Celgene Corporation |
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
|
US20030224469A1
(en)
|
2002-06-03 |
2003-12-04 |
Buchholz Tonia J. |
Methods and kits for assays utilizing fluorescence polarization
|
|
US7902185B2
(en)
|
2002-06-03 |
2011-03-08 |
Als Therapy Development Foundation, Inc. |
Treatment of neurodegenerative diseases using proteasome modulators
|
|
US20040167139A1
(en)
|
2002-07-26 |
2004-08-26 |
Potter David A. |
Methods of treating cancer
|
|
US7189740B2
(en)
|
2002-10-15 |
2007-03-13 |
Celgene Corporation |
Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes
|
|
TW200418791A
(en)
|
2003-01-23 |
2004-10-01 |
Bristol Myers Squibb Co |
Pharmaceutical compositions for inhibiting proteasome
|
|
KR101367574B1
(ko)
|
2003-04-08 |
2014-02-25 |
미쓰비시 타나베 파마 코퍼레이션 |
Ｓ1ｐ 수용체 아고니스트 및 당 알콜을 포함하는 고형 제약 조성물
|
|
AU2004255564A1
(en)
|
2003-06-10 |
2005-01-20 |
The J. David Gladstone Institutes |
Methods for treating lentivirus infections
|
|
US7012063B2
(en)
|
2003-06-13 |
2006-03-14 |
Children's Medical Center Corporation |
Reducing axon degeneration with proteasome inhibitors
|
|
KR20070007075A
(ko)
|
2003-12-31 |
2007-01-12 |
사이덱스 인크 |
술포알킬 에테르 시클로덱스트린 및 코르티코스테로이드를함유한 흡입용 제형
|
|
GB0400804D0
(en)
|
2004-01-14 |
2004-02-18 |
Innoscience Technology Bv |
Pharmaceutical compositions
|
|
US8129346B2
(en)
|
2004-04-15 |
2012-03-06 |
Onyx Therapeutics, Inc. |
Compounds for enzyme inhibition
|
|
US8198270B2
(en)
|
2004-04-15 |
2012-06-12 |
Onyx Therapeutics, Inc. |
Compounds for proteasome enzyme inhibition
|
|
US7232818B2
(en)
|
2004-04-15 |
2007-06-19 |
Proteolix, Inc. |
Compounds for enzyme inhibition
|
|
US20050256324A1
(en)
|
2004-05-10 |
2005-11-17 |
Proteolix, Inc. |
Synthesis of amino acid keto-epoxides
|
|
CA2565407A1
(en)
|
2004-05-10 |
2005-11-24 |
Proteolix, Inc. |
Compounds for enzyme inhibition
|
|
US20060088471A1
(en)
|
2004-10-20 |
2006-04-27 |
Proteolix, Inc. |
Compounds for enzyme inhibition
|
|
ES2549763T3
(es)
|
2004-12-07 |
2015-11-02 |
Onyx Therapeutics, Inc. |
Composición para inhibición del proteasoma
|
|
US7468383B2
(en)
*
|
2005-02-11 |
2008-12-23 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
|
WO2006099261A2
(en)
*
|
2005-03-11 |
2006-09-21 |
The University Of North Carolina At Chapel Hill |
Potent and specific immunoproteasome inhibitors
|
|
EP1876893B1
(en)
|
2005-04-15 |
2012-04-11 |
Geron Corporation |
Cancer treatment by combined inhibition of proteasome and telomerase activities
|
|
GT200600350A
(es)
|
2005-08-09 |
2007-03-28 |
|
Formulaciones líquidas
|
|
KR101434522B1
(ko)
|
2005-11-09 |
2014-08-26 |
오닉스 세라퓨틱스, 인크. |
효소 저해를 위한 화합물
|
|
AR057227A1
(es)
|
2005-12-09 |
2007-11-21 |
Centocor Inc |
Metodo para usar antagonistas de il6 con inhibidores del proteasoma
|
|
US20070207950A1
(en)
|
2005-12-21 |
2007-09-06 |
Duke University |
Methods and compositions for regulating HDAC6 activity
|
|
WO2007122686A1
(ja)
|
2006-04-14 |
2007-11-01 |
Eisai R & D Management Co., Ltd. |
ベンズイミダゾール化合物
|
|
DE102006026464A1
(de)
|
2006-06-01 |
2007-12-06 |
Virologik Gmbh Innovationszentrum Medizintechnik Und Pharma |
Pharmazeutische Zusammensetzung zur Behandlung von Virusinfektionen und / oder Tumorerkrankungen durch Inhibition der Proteinfaltung und des Proteinabbaus
|
|
US7691852B2
(en)
*
|
2006-06-19 |
2010-04-06 |
Onyx Therapeutics, Inc. |
Compounds for enzyme inhibition
|
|
WO2008033807A2
(en)
|
2006-09-13 |
2008-03-20 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Synergistic combinations of antineoplastic thiol-binding mitochondrial oxidants and antineoplastic proteasome inhibitors for the treatment of cancer
|
|
JP2010516767A
(ja)
|
2007-01-23 |
2010-05-20 |
グラスター ファーマシューティカルズ， インコーポレイテッド |
ロミデプシンおよびｉ．ａ．ボルテゾミブを含む併用療法
|
|
WO2008140782A2
(en)
|
2007-05-10 |
2008-11-20 |
Proteolix, Inc. |
Compounds for enzyme inhibition
|
|
CN101772507B
(zh)
|
2007-08-06 |
2012-12-12 |
米伦纽姆医药公司 |
蛋白酶体抑制剂
|
|
US7442830B1
(en)
|
2007-08-06 |
2008-10-28 |
Millenium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
|
RS54847B2
(sr)
|
2007-10-04 |
2019-09-30 |
Onyx Therapeutics Inc |
Inhibitori kristalne peptid epoksi keton proteaze i sinteza aminokiselinskih keto-epoksida
|
|
US7838673B2
(en)
|
2007-10-16 |
2010-11-23 |
Millennium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
|
WO2009051581A1
(en)
|
2007-10-16 |
2009-04-23 |
Millennium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
|
WO2009067453A1
(en)
|
2007-11-19 |
2009-05-28 |
Syndax Pharmaceuticals, Inc. |
Combinations of hdac inhibitors and proteasome inhibitors
|
|
EP2730580A1
(en)
|
2008-06-17 |
2014-05-14 |
Millennium Pharmaceuticals, Inc. |
Boronate ester compounds and pharmaceutical compositions thereof
|
|
AR075090A1
(es)
*
|
2008-09-29 |
2011-03-09 |
Millennium Pharm Inc |
Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
|
|
JP5675629B2
(ja)
|
2008-10-21 |
2015-02-25 |
オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
ペプチドエポキシケトンを用いた併用療法
|
|
AR075899A1
(es)
|
2009-03-20 |
2011-05-04 |
Onyx Therapeutics Inc |
Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
|
|
CN101928329B
(zh)
*
|
2009-06-19 |
2013-07-17 |
北京大学 |
三肽硼酸(酯)类化合物、其制备方法和应用
|
|
JP5919196B2
(ja)
|
2009-11-13 |
2016-05-18 |
オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
転移抑制のためのペプチドエポキシケトンの使用
|
|
MA34133B1
(fr)
|
2010-03-01 |
2013-04-03 |
Onyx Therapeutics Inc |
Composes pour inhibiteurs de l'immunoproteasome
|
|
UA110612C2
(uk)
|
2010-03-31 |
2016-01-25 |
Мілленніум Фармасьютікалз, Інк. |
Похідні 1-аміно-2-циклопропілетилборонової кислоти
|
|
WO2011136905A2
(en)
|
2010-04-07 |
2011-11-03 |
Onyx Therapeutics, Inc. |
Crystalline peptide epoxyketone immunoproteasome inhibitor
|
|
FR2962092B1
(fr)
*
|
2010-06-30 |
2013-06-28 |
Valeo Systemes Dessuyage |
Adaptateur d'essuie-glace a contacts electriques
|